These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 3688897)
1. [Complications due to high-dose OK-432 administration into tumors and the peritoneal cavity in patients with advanced gastric cancer]. Fukasawa K; Shiraishi M; Tachibana M; Utsumi Y; Nakamura T Gan To Kagaku Ryoho; 1987 Dec; 14(12):3365-8. PubMed ID: 3688897 [TBL] [Abstract][Full Text] [Related]
2. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients. Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625 [TBL] [Abstract][Full Text] [Related]
3. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer]. Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269 [TBL] [Abstract][Full Text] [Related]
4. The endoscopic intratumor administration of OK-432 in gastric cancer unsuitable for surgery. Nakazawa S; Yoshino J; Kijima Y; Yasumasa N; Ohhashi S; Mizutani K Endoscopy; 1989 Jul; 21(4):168-71. PubMed ID: 2776702 [TBL] [Abstract][Full Text] [Related]
5. [A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study]. Yamamura Y; Yasue M; Nakazato H; Ota K Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):541-8. PubMed ID: 3923941 [TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor]. Kato H; Kondo Y; Tanigawa M; Kin R; Sugino S; Kondo M Gan To Kagaku Ryoho; 1986 Oct; 13(11):3251-5. PubMed ID: 3777961 [TBL] [Abstract][Full Text] [Related]
7. [Clinical investigation of intratumoral OK-432 administration]. Shimada K; Tabuse K; Kono N; Katsumi M; Yamamoto H; Yamamoto Y; Endo A Gan To Kagaku Ryoho; 1983 Aug; 10(8):1844-9. PubMed ID: 6882008 [TBL] [Abstract][Full Text] [Related]
8. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer]. Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507 [TBL] [Abstract][Full Text] [Related]
10. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment. Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836 [TBL] [Abstract][Full Text] [Related]
11. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432]. Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202 [TBL] [Abstract][Full Text] [Related]
12. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results]. Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880 [TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic effects of a large dose injection of OK-432 (picibanil)]. Morita K; Murata T; Marumoto M; Tsuboi H; Nakahara Y; Oda T; Mohri H Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):295-300. PubMed ID: 6674797 [TBL] [Abstract][Full Text] [Related]
14. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection]. Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244 [TBL] [Abstract][Full Text] [Related]
15. [A case of unresectable advanced gastric cancer with effective treatment by local administration of OK-432 on operation]. Kodama M; Taniguchi T; Furukawa H; Takahashi T; Hara T Gan To Kagaku Ryoho; 1989 Jun; 16(6):2301-3. PubMed ID: 2735772 [TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy of gastric cancer]. Kan N; Ohgaki K; Okino T; Nakanishi M; Nio Y; Inoue K; Tobe T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):755-62. PubMed ID: 3291771 [TBL] [Abstract][Full Text] [Related]
17. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma. Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512 [TBL] [Abstract][Full Text] [Related]
18. [A case of recurrence of gastric cancer with an abdominal wall tumor responding to intratumoral OK-432 administration]. Saeki T; Kuninobu H; Niimoto M; Hattori T; Ohoya M; Yoshida H; Sata H; Kajitani Y Gan No Rinsho; 1987 Apr; 33(4):417-20. PubMed ID: 2952818 [TBL] [Abstract][Full Text] [Related]
19. [Endoscopic administration of OK-432 in gastric cancer]. Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375 [TBL] [Abstract][Full Text] [Related]
20. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432]. Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]